Previous close | 0.3050 |
Open | 0.3050 |
Bid | 0.3000 x 0 |
Ask | 0.3100 x 0 |
Day's range | 0.3050 - 0.3050 |
52-week range | 0.2200 - 0.4650 |
Volume | |
Avg. volume | 19,908 |
Market cap | 23.614M |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0200 |
Earnings date | 21 Aug 2024 - 26 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Aurora Spine to hold its Annual General Meeting on 26th of June Total pay for CEO Trent Northcutt includes...
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for first quarter ended March 31, 2024. All figures are in U.S. dollars. Financial and Business Highlights Positive EBITDAC – Q1 2024 EBITDAC was $117,17
CARLSBAD, Calif. , May 13, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it has scheduled a conference call to update investors and discuss its first quarter fiscal 2024 financial results that ended March 31, 2024. Management will host the conference call on Tuesday May 14, 2024 at 11:00 a.m. Eastern Time. First Quarter